DeNovo NT Longitudinal Data Collection (LDC) Knee Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-02-28

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the long-term outcomes of DeNovo NT, a tissue product used for the repair of cartilage damage in the knee. This product has been on the market since 2007 and implanted in more than 10,000 patients around the country.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Post Market Study of DeNovo NT, Natural Tissue Graft

NCT00791245

Cartilage Repair

COMPLETED

DeNovo NT Ankle LDC Study

NCT01347892

Defect of Articular Cartilage Osteochondral Lesion of Talus Osteochondritis Dissecans

UNKNOWN

DeNovo NT Natural Tissue Graft Stratified Knee Study

NCT01670617

Defect of Articular Cartilage Knee Injuries

UNKNOWN NA

Long-term Outcome Evaluation of Patients Undergoing Autologous Chondrocyte Transplantation Delivered on Biomaterial

NCT06238947

Cartilage Injury Cartilage Disease

NOT_YET_RECRUITING

Long Term Foundation Knee Study

NCT01274546

Total Knee Replacement

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Knee cartilage injury is a major cause of pain and functional impairment in young to middle age adults, and can lead to progressive joint degeneration. Adult cartilage has little regenerative capacity and many of the current treatment options have limited or unknown durability. DeNovo NT is an allogeneic tissue graft, prepared from donated juvenile cartilage, which has been shown to have a higher chondrogenic potential than adult cartilage. The graft involves a single surgery with no need for scaffolds, flaps or donor-site morbidity. This study will follow the long-term outcomes and durability of DeNovo NT in patients grafted with this product in the knee, for up to five years. It will enroll subjects prospectively (at the time of surgery) and retrospectively (those who have been previously implanted). Data will be collected on patient-reported outcomes, results of knee examinations, and reoperations and revisions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Degenerative Lesion of Articular Cartilage of Knee Osteochondritis Dissecans

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DeNovo NT patient

Patients who have received or who are scheduled to receive a DeNovo NT graft for repair of 1-2 knee cartilage lesions.

DeNovo NT, Natural Tissue Graft

Intervention Type OTHER

DeNovo NT Natural Tissue Graft of 1 or 2 lesions up to 5 cm squared in area.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DeNovo NT, Natural Tissue Graft

DeNovo NT Natural Tissue Graft of 1 or 2 lesions up to 5 cm squared in area.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

DeNovo NT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has a contained articular cartilage lesion(s) of the knee or Osteochondritis Dissecans OCD lesion(s) of the knee for which arthroscopic or surgical intervention is warranted, OR Has had prior treatment with DeNovo NT for a contained articulare cartilage lesion(so of the knee or Osteochondritis Dissecans OCD lesion(s) of the knee
* Has voluntarily signed the IRB approved Informed Consent
* Is of stable health and is able to undergo surgery
* Is male or female over the age of 18 years
* Is physically and mentally willing and able to comply with post-operative rehabilitation and routinely scheduled clinical visits

Exclusion Criteria

* Displays a high surgical risk as determined by the investigative surgeon
* Is pregnant or breast-feeding
* Has a clinically diagnosed autoimmune disease
* Has an active joint infection or history of chronic joint infection at the surgical site
* Has damage to the subchondral bone that has not/will not be repaired prior to DeNovo NT treatment

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No